Inclusion Criteria:  Male subjects, ages 18 - 75 years old. ASA Physical Status Classification System Class I and Class II subjects. Clinical diagnosis of primary or secondary Gynecomastia. Gynecomastia Rohrich Grade IIA or higher. Symmetrical gynecomastia Rohrich grades. Symmetrical chest measurements (no more than 3% variance between sides). Scheduled for Gynecomastia surgery. Willing to have Renuvion APR System as an adjunct procedure on one side understanding that an optional balancing procedure may be provided post-study exit. Understands and accepts the obligation not to undergo any other procedures or treatments in the areas to be treated during study participation. Absence of physical conditions unacceptable to the investigator. Willing and able to comply with protocol requirements, including study-required images/photos, assessments/measurements, and returning for follow-up visits. Willing to release rights for the use of study photos, including in publication. Able to read, understand, sign, and date the informed consent.  Exclusion Criteria:  Subjects without clinical diagnosis of primary Gynecomastia and/or a clinical diagnosis of gynecomastia with secondary causes such as medications, drugs, or testicular tumors. Subjects presenting with ASA Physical Status Classification System Classes III or higher. Gynecomastia Rohrich Grade I. Non-symmetrical gynecomastia Rohrich grades. Non-symmetrical chest measurements (more than 3% variance between sides). Previous treatment or surgery in the breast area. Active systemic or local skin disease that may alter wound healing. Significant or uncontrolled medical condition that in the opinion of the investigator participation in the study may compromise the patient's health. History of autoimmune disease (excluding Hashimoto's thyroiditis). Known susceptibility to keloid formation or hypertrophic scarring. Cancerous or pre-cancerous lesions in the area to be treated. Possesses a surgically implanted electronic device (i.e. pacemaker). Serious mental health illness such as dementia or schizophrenia; psychiatric hospitalization in the past two years. Use of endermology post-procedure for the duration of the study. Participation in any other investigational study within 30 days prior to consent and throughout study participation. Subject who, in the opinion of the investigator, is not an appropriate candidate for the study.